drugset / Trial / NCT07338357
Clinical Study of CLL-1 CAR-T in the Treatment of Children With R/R AML
Phase 0
Not yet recruiting
10 enrolled
First Affiliated Hospital of Guangxi Medical University
Guangzhou Bio-gene Technology Co., Ltd · collab
NaSingle-groupOpen-labelTreatment
Summary
A study to evaluate the safety and preliminary efficacy of CLL-1-targeted CAR-T cell therapy in children aged 3 to 18 years with relapsed or refractory acute myeloid leukemia (r/r AML).
Timeline
- Start
- 2026-01-05
- Primary completion
- 2028-10-31
- Completion
- 2028-10-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CLL1 CAR-T | Cell therapy | — | — |